- Home
- TLSI vs MDV Comparison
TLSI vs MDV Comparison
Compare TLSI & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- MDV
- Stock Information
- Founded
- TLSI 2010
- MDV 2015
- Country
- TLSI United States
- MDV United States
- Employees
- TLSI N/A
- MDV N/A
- Industry
- TLSI Medical Specialities
- MDV Transportation Services
- Sector
- TLSI Health Care
- MDV Consumer Discretionary
- Exchange
- TLSI Nasdaq
- MDV Nasdaq
- Market Cap
- TLSI 150.0M
- MDV 147.6M
- IPO Year
- TLSI N/A
- MDV 2022
- Fundamental
- Price
- TLSI $3.94
- MDV $14.79
- Analyst Decision
- TLSI Strong Buy
- MDV
- Analyst Count
- TLSI 5
- MDV 0
- Target Price
- TLSI $10.90
- MDV N/A
- AVG Volume (30 Days)
- TLSI 73.5K
- MDV 43.0K
- Earning Date
- TLSI 08-12-2025
- MDV 08-07-2025
- Dividend Yield
- TLSI N/A
- MDV 7.52%
- EPS Growth
- TLSI N/A
- MDV N/A
- EPS
- TLSI N/A
- MDV N/A
- Revenue
- TLSI $35,990,000.00
- MDV $47,273,000.00
- Revenue This Year
- TLSI $55.39
- MDV $2.21
- Revenue Next Year
- TLSI $54.89
- MDV $4.45
- P/E Ratio
- TLSI N/A
- MDV N/A
- Revenue Growth
- TLSI 45.50
- MDV N/A
- 52 Week Low
- TLSI $3.42
- MDV $13.62
- 52 Week High
- TLSI $6.04
- MDV $18.11
- Technical
- Relative Strength Index (RSI)
- TLSI 39.84
- MDV 61.06
- Support Level
- TLSI $3.42
- MDV $14.35
- Resistance Level
- TLSI $4.00
- MDV $15.65
- Average True Range (ATR)
- TLSI 0.36
- MDV 0.37
- MACD
- TLSI -0.01
- MDV 0.09
- Stochastic Oscillator
- TLSI 34.75
- MDV 70.39
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About MDV Modiv Industrial Inc. Class C
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.